Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease.

ABSTRACT:

SUBMITTER: Norrbacka S 

PROVIDER: S-EPMC6850970 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature